Results from 2 randomized, double-blind, placebo-controlled studies of the novel nk1 receptor antagonist casopitant in patients with major depressive disorder
10.1097/JCP.0b013e31823608ca
Saved in:
Main Authors: | Ratti, E., Bellew, K., Bettica, P., Bryson, H., Zamuner, S., Archer, G., Squassante, L., Bye, A., Trist, D., Krishnan, K.R., Fernandes, S. |
---|---|
Other Authors: | DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/110626 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Zika virus infection preferentially counterbalances human peripheral monocyte and/or NK cell activity
by: Lum, Fok-Moon, et al.
Published: (2020) -
THE ROLE OF NK CELL METABOLISM IN NK CELL ACTIVATION AND FUNCTION
by: WANG ZIXI
Published: (2020) -
Advances in NKG2D ligand recognition and responses by NK cells
by: Le Bert, N., et al.
Published: (2016) -
Leukotriene receptor antagonists
by: Van Bever, H.P.S.
Published: (2014) -
The role of nk cells in ebv infection and ebv-associated npc
by: Png, Yi Tian, et al.
Published: (2022)